The reduction of integrin expression also inhibited thyroxine-induced ERK1/2 activation (Figure 2C), implicating integrin αvβ3 is involved in the activation of MAPK by thyroid hormone in ovarian cancer cells. This evidence concerns the gene MAPK3 and ovarian cancer.